Brown Emery N. 4
4 · Humacyte, Inc. · Filed Jun 16, 2025
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Brown Emery N.
Director
Transactions
- Award
Stock Options (right to buy)
2025-06-12+80,000→ 80,000 totalExercise: $2.41Exp: 2035-06-12→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]The first 25% of the option becomes exercisable on June 12, 2026, after which 1/48 of the option will become exercisable on the 12th of each month through June 12, 2029.